PAP
FHTX icon

Persistent Asset Partners’s Foghorn Therapeutics FHTX Stock Holding History

Persistent Asset Partners’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Sell
46,644
-464
-1% -$2.55K 0.08% 185
2025
Q4 		$254K Buy
47,108
+35,667
+312% +$162K 0.11% 198
2025
Q3 		$55.9K Buy
+11,441
New +$60.7K 0.04% 176

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Persistent Asset Partners's FHTX Position: Q1 2026 in Review

Persistent Asset Partners reduced its Foghorn Therapeutics (FHTX) stake by 0.98% in Q1 2026, selling an estimated $2.55K and leaving 46,644 shares worth $223K. The position accounts for 0.08% of the portfolio, ranked #185.

Persistent Asset Partners first reported a position in FHTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $254K in Q4 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Persistent Asset Partners held 46,644 shares of Foghorn Therapeutics worth $223K as of Q1 2026.
  • Persistent Asset Partners sold 464 Foghorn Therapeutics shares in Q1 2026, an estimated $2.55K.
  • Foghorn Therapeutics made up 0.08% of Persistent Asset Partners's portfolio in Q1 2026, its #185 holding.
  • Persistent Asset Partners first reported a position in Foghorn Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's Foghorn Therapeutics position peaked at $254K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.